Free Trial

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 11,119 Shares of Trupanion, Inc. (NASDAQ:TRUP)

Trupanion logo with Finance background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 14.2% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 89,184 shares of the financial services provider's stock after buying an additional 11,119 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.21% of Trupanion worth $4,299,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of the company. Jones Financial Companies Lllp increased its stake in Trupanion by 71.7% in the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider's stock valued at $27,000 after buying an additional 238 shares during the period. Coppell Advisory Solutions LLC grew its stake in shares of Trupanion by 58.3% during the 4th quarter. Coppell Advisory Solutions LLC now owns 1,249 shares of the financial services provider's stock worth $61,000 after purchasing an additional 460 shares during the period. SBI Securities Co. Ltd. acquired a new position in shares of Trupanion during the 4th quarter worth $25,000. Swiss National Bank grew its stake in shares of Trupanion by 1.1% during the 4th quarter. Swiss National Bank now owns 66,310 shares of the financial services provider's stock worth $3,196,000 after purchasing an additional 700 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Trupanion by 4.0% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 18,745 shares of the financial services provider's stock worth $904,000 after purchasing an additional 717 shares during the period.

Insider Buying and Selling at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 2,534 shares of Trupanion stock in a transaction dated Thursday, May 29th. The stock was sold at an average price of $48.31, for a total transaction of $122,417.54. Following the transaction, the chief financial officer now owns 3,545 shares of the company's stock, valued at $171,258.95. The trade was a 41.68% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO John R. Gallagher sold 4,000 shares of Trupanion stock in a transaction dated Thursday, May 29th. The shares were sold at an average price of $47.90, for a total value of $191,600.00. Following the transaction, the chief operating officer now directly owns 26,966 shares in the company, valued at approximately $1,291,671.40. This trade represents a 12.92% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 41,487 shares of company stock worth $1,538,966. 5.42% of the stock is owned by insiders.

Trupanion Stock Down 1.2%

Shares of Trupanion stock traded down $0.57 on Thursday, hitting $47.58. 395,576 shares of the company's stock traded hands, compared to its average volume of 609,868. The stock has a market cap of $2.04 billion, a P/E ratio of -206.87, a PEG ratio of 6.02 and a beta of 1.72. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The firm's 50-day moving average is $40.55 and its 200 day moving average is $43.83. Trupanion, Inc. has a 52-week low of $25.90 and a 52-week high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, topping analysts' consensus estimates of ($0.05) by $0.02. The firm had revenue of $341.98 million during the quarter, compared to the consensus estimate of $337.81 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The firm's revenue was up 11.7% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.16) earnings per share. Equities analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently weighed in on TRUP. Piper Sandler lowered their price target on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research note on Thursday, February 20th. Lake Street Capital lowered their price target on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Finally, Stifel Nicolaus decreased their price objective on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Trupanion currently has a consensus rating of "Moderate Buy" and an average price target of $51.80.

Check Out Our Latest Report on TRUP

Trupanion Profile

(Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Stories

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

Should You Invest $1,000 in Trupanion Right Now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines